Internal Medicine, Rheumatology · Annapolis, MD
NPI
1205879111
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
128 Lubrano Dr, Suite 201
Annapolis, MD, 21401
Phone (410) 897-1941
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
63,556 services
Medicare patients, 2024
440
Average age 75
Drug cost, 2024
$1.5M
1,875 prescriptions
Company payments, 2025
$2,627
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Susan M Berger was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 34,400 times for 12 patients. In total Susan M Berger billed 63,556 services in 37 codes, and Medicare paid $1.4M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-10.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 34,400 | 12 | $3.62 | $124K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 11,925 | 18 | $33.86 | $404K |
| J0897 Injection, denosumab, 1 mg | Office | 7,140 | 71 | $20.42 | $146K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 686 | 322 | $12.71 | $8,720 |
| 99214 Office E&M - Established | Office | 466 | 260 | $94.32 | $44K |
| 96401 Chemotherapy Administration | Office | 298 | 86 | $60.22 | $18K |
| 99215 Office E&M - Established | Office | 252 | 150 | $139.22 | $35K |
| 96413 Chemotherapy Administration | Office | 183 | 26 | $108.84 | $20K |
| 99205 Office E&M - New | Office | 107 | 107 | $165.90 | $18K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 86 | 32 | $51.75 | $4,451 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 81 | 31 | $39.71 | $3,217 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 61 | 13 | $0.71 | $43.33 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 59 | 19 | $51.23 | $3,023 |
| 99204 Office E&M - New | Office | 21 | 21 | $124.78 | $2,620 |
| 96375 Injection Administration | Office | 18 | 11 | $12.83 | $231 |
By year: 2022 $687K for 60,787 services; 2023 $774K for 60,280 services; 2024 $1.4M for 63,556 services.
Medicare prescription drug claims, 2024
In 2024, the drug Susan M Berger prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 372 prescriptions and refills. In total Susan M Berger wrote 1,875 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 372 | 896 | 107 | $21K |
| Prednisone Generic | 303 | 355 | 62 | $1,916 |
| Methotrexate Methotrexate Sodium | 188 | 486 | 53 | $8,633 |
| Leflunomide Generic | 97 | 229 | 29 | $9,350 |
| Otezla Apremilast | 91 | 121 | 15 | $591K |
| Tramadol Hcl Generic | 82 | 116 | 19 | $775 |
| Celecoxib Generic | 49 | 119 | 19 | $1,482 |
| Allopurinol Generic | 39 | 117 | 12 | $412 |
| Duloxetine Hcl Generic | 31 | 89 | Under 11 | $672 |
| Meloxicam Generic | 30 | 54 | Under 11 | $69.43 |
| Colchicine Generic | 30 | 48 | Under 11 | $2,551 |
| Xeljanz Xr Tofacitinib Citrate | 26 | 32 | Under 11 | $185K |
| Methylprednisolone Generic | 25 | 25 | 14 | $78.37 |
| Febuxostat Generic | 25 | 67 | Under 11 | $5,015 |
| Sulfasalazine Dr Sulfasalazine | 23 | 49 | Under 11 | $1,019 |
Brand drugs: 240 claims; generic drugs: 1,635 claims; opioid claims: 118.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Susan M Berger $2,627 ($2,627 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $595.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 49 | $595 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $328 |
| Janssen Biotech, Inc. JNJ | 6 | $255 |
| UCB, Inc. UCB.BR | 19 | $222 |
| Sobi, Inc SOBI.ST | 5 | $206 |
| Amgen Inc. AMGN | 15 | $195 |
| Pfizer Inc. PFE | 15 | $195 |
| ANI Pharmaceuticals, Inc. ANIP | 9 | $140 |
| GlaxoSmithKline, LLC. GSK | 4 | $96.69 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $74.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.